Article Text

Download PDFPDF
Systematic review and meta-analysis
Metabolic monitoring for patients on antipsychotic medication: are we failing to provide reasonable standard of physical healthcare?
  1. Valsamma Eapen
  1. Department of Psychiatry, University of New South Wales, Sydney, Australia
  1. Correspondence to Valsamma Eapen
    Department of Psychiatry, University of New South Wales, L1 Mental Health centre, Elizabeth Street, Sydney, NSW 2170, Australia; v.eapen{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Commentary on: OpenUrlCrossRefPubMed

Implications for practice and research

  • Patients with mental illness are vulnerable to weight gain and metabolic risk induced by antipsychotic medication, therefore, proactive monitoring and management are critical in improving outcomes.

  • Suboptimal metabolic monitoring even after the introduction of monitoring guidelines suggests the need for matching guidelines with appropriate training and quality assurance programmes.

  • There is a need to bridge the research gap through investigating the optimal methods of detecting, preventing and treating metabolic risk in mentally-ill patients; the implementation of effective monitoring methods is crucial.

  • An integrated evidence-based approach linking physical and mental health aspects using a shared care …

View Full Text


  • Competing interests None.